Latest Period
n/a
Security Snapshot
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) Institutional Ownership
CUSIP: G2161P140
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.34
- Type / Class
- Equity / Common stock, $0.08 par value
- Symbol
- SXTC on Nasdaq
- Price per share
- $0.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value is tracked under CUSIP G2161P140.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 2 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $5,085 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP G2161P140?
CUSIP G2161P140 identifies SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G2161P140:
Institutional Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$5,085 | $0.34 | 0 |
| 2024 Q4 | 10,008 | $5,085 | -$21,536 | $0.50 | 2 |
| 2024 Q3 | 46,515 | $29,956 | -$39,375 | $0.73 | 5 |
| 2024 Q2 | 73,359 | $79,938 | +$77,818 | $1.08 | 6 |
| 2024 Q1 | 2,870 | $3,186 | -$10,232 | $1.62 | 3 |
| 2023 Q4 | 9,170 | $35,452 | +$35,452 | $3.97 | 3 |